IRCCS, Istituto delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria Infantile, Bologna, Italia.
IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia.
Epileptic Disord. 2020 Dec 1;22(6):802-806. doi: 10.1684/epd.2020.1222.
Although the classic phenotype of episodic ataxia type 1 (EA1) caused by variants in KCNA1 includes episodic ataxia and myokymia, further genotype-phenotype correlations are difficult to establish due to highly heterogeneous clinical presentations associated with KCNA1 pathogenic variants. De novo variants in the paralogous Pro-Val-Pro motif (PVP) of KCNA2, an essential region for channel gating, have been reported to be associated with severe epilepsy phenotypes, including developmental and epileptic encephalopathies (DEE). Here, we describe the first patient with a DEE who developed an encephalopathy related to status epilepticus during sleep (ESES) and cerebellar signs, harbouring a variant in the Kv-specific PVP motif of the KCNA1 gene. Interestingly, he showed a remarkable long-term electroclinical response to IM ACTH therapy. This report extends the range of phenotypes associated with KCNA1 variants to include that of ESES, and suggests that ACTH therapy is likely to have a positive effect in patients with these variants.
尽管由 KCNA1 变异引起的发作性共济失调 1 型(EA1)的经典表型包括发作性共济失调和肌阵挛,但由于与 KCNA1 致病性变异相关的临床表现高度异质性,进一步的基因型-表型相关性难以确定。Kv 特异性 PVP 基序(PVP)中 KCNA2 的从头变异,该基序对于通道门控至关重要,已被报道与严重的癫痫表型相关,包括发育性和癫痫性脑病(DEE)。在这里,我们描述了首例与睡眠相关癫痫持续状态(ESES)和小脑征相关的 DEE 患者,该患者携带 KCNA1 基因 Kv 特异性 PVP 基序中的变异。有趣的是,他对 IM ACTH 治疗表现出显著的长期电临床反应。本报告将与 KCNA1 变异相关的表型范围扩展到包括 ESES,并表明 ACTH 治疗可能对这些变异患者有积极影响。